{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:54:56Z","timestamp":1790834096829,"version":"4.1.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001786","name":"University of Adelaide","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000950","name":"Cancer Council South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000926","name":"Leukaemia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000926","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.canlet.2019.11.005","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T11:22:50Z","timestamp":1573039370000},"page":"410-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["KMT2A rearranged acute lymphoblastic leukaemia: Unravelling the genomic complexity and heterogeneity of this high-risk disease"],"prefix":"10.1016","volume":"469","author":[{"given":"Michelle O.","family":"Forgione","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"McClure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura N.","family":"Eadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.11.005_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fped.2017.00004","article-title":"MLL-rearranged leukemias-an update on science and clinical approaches","volume":"5","author":"Winters","year":"2017","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.canlet.2019.11.005_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-pathol-011811-132434","article-title":"The pathogenesis of mixed-lineage leukemia","volume":"7","author":"Muntean","year":"2012","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.canlet.2019.11.005_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2016.69.0073","article-title":"High frequency and poor outcome of philadelphia chromosome-like acute lymphoblastic leukemia in adults","volume":"35","author":"Roberts","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.11.005_bib4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjh.13174","volume":"168","author":"Kato","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2019.11.005_bib5","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3324\/haematol.2012.081877","article-title":"The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)\/MLL-AFF1 prospectively treated in the UKALLXII\/ECOG2993 trial","volume":"98","author":"Marks","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2019.11.005_bib6","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1182\/blood-2015-09-667378","article-title":"Revisiting the biology of infant t (4; 11)\/MLL-AF4+ B-cell acute lymphoblastic leukemia","volume":"126","author":"Sanjuan-Pla","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.11.005_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10428194.2016.1177182","article-title":"Frequency and prognostic significance of t(v;11q23)\/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols","volume":"58","author":"Motll\u00f3","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.canlet.2019.11.005_bib8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/pbc.25953","article-title":"Lineage switch in MLL-rearranged infant leukemia following CD19-directed therapy","volume":"63","author":"Rayes","year":"2016","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.canlet.2019.11.005_bib9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1182\/blood-2005-08-3498","article-title":"A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy","volume":"108","author":"Chen","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.11.005_bib10","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1038\/sj.onc.1209636","article-title":"A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology","volume":"25","author":"Metzler","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.11.005_bib11","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/leu.2011.15","article-title":"Activated K-Ras protein accelerates human MLL\/AF4-induced leukemo-lymphomogenicity in a transgenic mouse model","volume":"25","author":"Tamai","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2019.11.005_bib12","doi-asserted-by":"crossref","first-page":"13950","DOI":"10.1073\/pnas.94.25.13950","article-title":"Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood\u2009spots","volume":"94","author":"Gale","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.canlet.2019.11.005_bib13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng.3230","article-title":"The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias","volume":"47","author":"Andersson","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2019.11.005_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bcp.2017.09.007","article-title":"How to effectively treat acute leukemia patients bearing MLL-rearrangements?","volume":"147","author":"Steinhilber","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2019.11.005_bib15","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/leu.2009.177","article-title":"Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation","volume":"23","author":"Ono","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2019.11.005_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3343\/alm.2016.36.2.85","article-title":"Systematic classification of mixed-lineage leukemia fusion partners predicts additional cancer pathways","volume":"36","author":"Marschalek","year":"2016","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.canlet.2019.11.005_bib17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.exphem.2015.05.012","article-title":"Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond","volume":"43","author":"Chen","year":"2015","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.canlet.2019.11.005_bib18","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1182\/blood.V66.5.1115.1115","article-title":"Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance","volume":"66","author":"Mirro","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.11.005_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fcell.2019.00081","article-title":"Rewiring the epigenetic networks in MLL-rearranged leukemias: epigenetic dysregulation and pharmacological interventions","volume":"7","author":"Chan","year":"2019","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.canlet.2019.11.005_bib20","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1023\/A:1008375931236","article-title":"The world Health organization classification of neoplastic diseases of the hematopoietic and lymphoid Tissues","volume":"10","author":"Harris","year":"1999","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2019.11.005_bib21","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.11.005_bib22","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"The Lancet"},{"key":"10.1016\/j.canlet.2019.11.005_bib23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/gcc.22666","article-title":"KMT2A (MLL) rearrangements observed in pediatric\/young adult T-lymphoblastic leukemia\/lymphoma: a 10-year review from a single cytogenetic laboratory","volume":"57","author":"Peterson","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.canlet.2019.11.005_bib24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","article-title":"The genetic basis and cell of origin of mixed phenotype acute leukaemia","volume":"562","author":"Alexander","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.11.005_bib25","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/s41467-018-04924-z","article-title":"Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes","volume":"9","author":"Takahashi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2019.11.005_bib26","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.5858\/arpa.2017-0218-RA","article-title":"Mixed-phenotype Acute leukemia: diagnostic criteria and pitfalls","volume":"141","author":"Charles","year":"2017","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.canlet.2019.11.005_bib27","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/leu.2016.60","article-title":"MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study","volume":"30","author":"Matlawska-Wasowska","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2019.11.005_bib28","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2019.11.005_bib29","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrc.2016.63","article-title":"The genetics and mechanisms of T cell acute lymphoblastic leukaemia","volume":"16","author":"Belver","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2019.11.005_bib30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/bjh.13613","article-title":"Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia","volume":"171","author":"Mansur","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2019.11.005_bib31","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1101\/gad.1741408","article-title":"Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia","volume":"22","author":"Guenther","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2019.11.005_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.26697","article-title":"Azacitidine successfully maintained the second remission in an infant with KMT2A-rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation","volume":"64","author":"Chijimatsu","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.canlet.2019.11.005_bib33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bjh.14474","article-title":"Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics","volume":"176","author":"Tasian","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2019.11.005_bib34","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2009-04-215152","article-title":"Novel prognostic subgroups in childhood 11q23\/MLL-rearranged acute myeloid leukemia: results of an international retrospective study","volume":"114","author":"Balgobind","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.11.005_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.gep.2014.05.001","article-title":"MLLT11\/AF1q is differentially expressed in maturing neurons during development","volume":"15","author":"Yamada","year":"2014","journal-title":"Gene Expr. Patterns"},{"key":"10.1016\/j.canlet.2019.11.005_bib36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1101\/gad.2015411","article-title":"The super elongation complex (SEC) and MLL in development and disease","volume":"25","author":"Smith","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2019.11.005_bib37","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/leu.2013.135","article-title":"The MLL recombinome of acute leukemias in 2013","volume":"27","author":"Meyer","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2019.11.005_bib38","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/leu.2013.78","article-title":"In focus: MLL-rearranged leukemia","volume":"27","author":"de Boer","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2019.11.005_bib39","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1182\/blood-2017-04-777185","article-title":"The full transforming capacity of MLL-Af4 is interlinked with lymphoid lineage commitment","volume":"130","author":"Lin","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.11.005_bib40","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/leu.2017.213","article-title":"The MLL recombinome of acute leukemias in 2017","volume":"32","author":"Meyer","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2019.11.005_bib41","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1182\/blood-2017-12-818948","article-title":"The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia","volume":"131","author":"Stein","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.11.005_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40364-018-0141-z","article-title":"Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL","volume":"6","author":"Kang","year":"2018","journal-title":"Biomark. Res."},{"key":"10.1016\/j.canlet.2019.11.005_bib43","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.1735.1735","article-title":"Landscape of somatic mutations and gene expression changes in relapsed infant MLL-rearranged acute lymphoblastic leukemia","volume":"128","author":"Kostadinov","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.11.005_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000249","article-title":"Misguided transcriptional elongation causes mixed lineage leukemia","volume":"7","author":"Mueller","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.canlet.2019.11.005_bib45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nrc3929","article-title":"Hijacked in cancer: the KMT2 (MLL) family of methyltransferases","volume":"15","author":"Rao","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2019.11.005_bib46","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/ped.12758","article-title":"Recent progress in the treatment of infant acute lymphoblastic leukemia","volume":"57","author":"Tomizawa","year":"2015","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.canlet.2019.11.005_bib47","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1182\/blood.V128.22.1740.1740","article-title":"Comparison of MRD levels and gene expression patterns in MLL-R versus non-MLL infant ALL","volume":"128","author":"Sutton","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.11.005_bib48","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1200\/JCO.19.00261","article-title":"Outcome of infants younger than 1 Year with acute lymphoblastic leukemia treated with the interfant-06 protocol: results from an international phase III randomized study","volume":"37","author":"Pieters","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.11.005_bib49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/pbc.25322","article-title":"Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3)","volume":"62","author":"Dreyer","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.canlet.2019.11.005_bib50","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","article-title":"A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial","volume":"370","author":"Pieters","year":"2007","journal-title":"The Lancet"},{"key":"10.1016\/j.canlet.2019.11.005_bib51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1182\/blood-2005-07-3011","article-title":"Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group","volume":"108","author":"Hilden","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.11.005_bib52","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1038\/leu.2014.142","article-title":"A revised definition for cure of childhood acute lymphoblastic leukemia","volume":"28","author":"Pui","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2019.11.005_bib53","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1200\/JCO.2010.30.1382","article-title":"Modern therapy of acute lymphoblastic leukemia","volume":"29","author":"Bassan","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.11.005_bib54","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1182\/blood.V95.8.2722","article-title":"Presence of clone-specific antigen receptor gene rearrangements at birth indicates an in utero origin of diverse types of early childhood acute lymphoblastic leukemia","volume":"95","author":"Fasching","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.11.005_bib55","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1182\/blood-2002-12-3817","article-title":"Leukemia in twins: lessons in natural history","volume":"102","author":"Greaves","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.11.005_bib56","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrc1164","article-title":"Origins of chromosome translocations in childhood leukaemia","volume":"3","author":"Greaves","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2019.11.005_bib57","doi-asserted-by":"crossref","first-page":"7429","DOI":"10.1073\/pnas.1221099110","article-title":"Developmental timing of mutations revealed by whole-genome sequencing of twins with acute lymphoblastic leukemia","volume":"110","author":"Ma","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2019.11.005_bib58","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41568-018-0015-6","article-title":"A causal mechanism for childhood acute lymphoblastic leukaemia","author":"Greaves","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2019.11.005_bib59","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bjh.15246","article-title":"Neonatal leukaemia","volume":"182","author":"Roberts","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2019.11.005_bib60","first-page":"2473","article-title":"Fetal and neonatal hematopoietic progenitors are exquisitely sensitive to MLL-ENL-driven leukemia initiation","volume":"130","author":"Owuor","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.11.005_bib61","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/leu.2010.284","article-title":"Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement","volume":"25","author":"Bueno","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2019.11.005_bib62","doi-asserted-by":"crossref","first-page":"e571","DOI":"10.3324\/haematol.2018.191718","article-title":"The fetal liver lymphoid-primed multipotent progenitor provides the prerequisites for the initiation of t(4;11) MLL-AF4 infant leukemia","volume":"103","author":"Malouf","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2019.11.005_bib63","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3324\/haematol.2018.206375","article-title":"Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis","volume":"104","author":"Agraz-Doblas","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2019.11.005_bib64","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1182\/blood-2010-12-322230","article-title":"Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia","volume":"117","author":"Montes","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.11.005_bib65","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1084\/jem.20091050","article-title":"Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene","volume":"206","author":"Menendez","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2019.11.005_bib66","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00109-009-0583-8","article-title":"Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia","volume":"88","author":"Shalapour","year":"2010","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.canlet.2019.11.005_bib67","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.trecan.2017.04.004","article-title":"Epigenetics and cancer stem cells: unleashing, hijacking, and restricting cellular plasticity","volume":"3","author":"Wainwright","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2019.11.005_bib68","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature13038","article-title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.11.005_bib69","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s12185-009-0446-7","article-title":"Early lineage switch in an infant acute lymphoblastic leukemia","volume":"90","author":"Sakaki","year":"2009","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.canlet.2019.11.005_bib70","doi-asserted-by":"crossref","first-page":"e607","DOI":"10.1038\/bcj.2017.89","article-title":"Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A\/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis","volume":"7","author":"Haddox","year":"2017","journal-title":"Blood Canc. J."},{"key":"10.1016\/j.canlet.2019.11.005_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12320","article-title":"CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity","volume":"7","author":"Jacoby","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2019.11.005_bib72","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/ajh.23266","article-title":"Lineage switch in childhood acute leukemia: an unusual event with poor outcome","volume":"87","author":"Rossi","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.canlet.2019.11.005_bib73","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/leu.2016.18","article-title":"The possible perils of targeted therapy","volume":"30","author":"Duffner","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2019.11.005_bib74","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/bloodadvances.2018018093","article-title":"Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in MLL-rearranged infant ALL","volume":"2","author":"Wolfl","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2019.11.005_bib75","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.3324\/haematol.2013.096750","article-title":"First description of the t(10;11)(q22;q23)\/MLL-TET1 translocation in a T-cell lymphoblastic lymphoma, with subsequent lineage switch to acute myelomonocytic myeloid leukemia","volume":"98","author":"Ittel","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2019.11.005_bib76","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc1816","article-title":"Infection, immune responses and the aetiology of childhood leukaemia","volume":"6","author":"Greaves","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2019.11.005_bib77","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/bjh.12250","article-title":"Brazilian Collaborative Study Group of Infant Acute, the distribution of MLL breakpoints correlates with outcome in infant acute leukaemia","volume":"161","author":"Emerenciano","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2019.11.005_bib78","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/pbc.23274","article-title":"MLL gene rearrangements in infant leukemia vary with age at diagnosis and selected demographic factors: a Children's Oncology Group (COG) study","volume":"58","author":"Sam","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.canlet.2019.11.005_bib79","doi-asserted-by":"crossref","unstructured":"M. Burns, S.A. Armstrong, A. Gutierrez, Pathobiology of Acute Lymphoblastic Leukemia, Hematology 2018, pp. 1005-1019.e1011.","DOI":"10.1016\/B978-0-323-35762-3.00064-0"},{"key":"10.1016\/j.canlet.2019.11.005_bib80","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/leu.2012.365","article-title":"Secondary mutations in t(4;11) leukemia patients","volume":"27","author":"Prelle","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2019.11.005_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26786","article-title":"Mutational status of NRAS, KRAS, and PTPN11 genes is associated with genetic\/cytogenetic features in children with B-precursor acute lymphoblastic leukemia","volume":"65","author":"Liang","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.canlet.2019.11.005_bib82","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.3324\/haematol.2017.169870","article-title":"The role of constitutive activation of FMS-related tyrosine kinase-3 and NRas\/KRas mutational status in infants with KMT2A rearranged acute lymphoblastic leukemia","volume":"102","author":"Fedders","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2019.11.005_bib83","doi-asserted-by":"crossref","first-page":"34449","DOI":"10.1038\/srep34449","article-title":"Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis","volume":"6","author":"Trentin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.11.005_bib84","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/bjh.13279","article-title":"Subclonality and prenatal origin of RAS mutations in KMT2A (MLL)\u2010rearranged infant acute lymphoblastic leukaemia","volume":"170","author":"Emerenciano","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2019.11.005_bib85","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3324\/haematol.2012.067983","article-title":"Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants","volume":"98","author":"Driessen","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2019.11.005_bib86","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1038\/ncomms4630","article-title":"The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes","volume":"5","author":"Huether","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2019.11.005_bib87","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","article-title":"MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L","volume":"20","author":"Bernt","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2019.11.005_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26251","article-title":"DNA methylation profiling of pediatric B-cell lymphoblastic leukemia with KMT2A rearrangement identifies hypomethylation at enhancer sites","volume":"64","author":"Bergmann","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.canlet.2019.11.005_bib89","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood-2018-04-785980","article-title":"How I treat infant leukemia","volume":"133","author":"Brown","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.11.005_bib90","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1182\/asheducation-2013.1.601","article-title":"Does hematopoietic stem cell transplantation benefit infants with acute leukemia?","volume":"1","author":"Sison","year":"2013","journal-title":"Hematology"},{"key":"10.1016\/j.canlet.2019.11.005_bib91","doi-asserted-by":"crossref","first-page":"444","DOI":"10.12688\/f1000research.10768.1","article-title":"Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy","volume":"6","author":"Schmiegelow","year":"2017","journal-title":"F1000Res."},{"key":"10.1016\/j.canlet.2019.11.005_bib92","doi-asserted-by":"crossref","first-page":"14835","DOI":"10.18632\/oncotarget.11730","article-title":"MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations","volume":"8","author":"Kerstjens","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.11.005_bib93","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.3324\/haematol.2017.174060","article-title":"Trametinib inhibits RAS mutant MLL-rearranged acute lymphoblastic leukemia at specific niche sites and reduces ERK phosphorylation in vivo","volume":"103","author":"Kerstjens","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2019.11.005_bib94","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1038\/leu.2012.161","article-title":"Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia","volume":"26","author":"Chill\u00f3n","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2019.11.005_bib95","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3389\/fonc.2014.00263","article-title":"The biology and targeting of FLT3 in pediatric leukemia","volume":"4","author":"Annesley","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2019.11.005_bib96","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1158\/1078-0432.CCR-15-1998","article-title":"A phase I study of quizartinib combined with chemotherapy in relapsed childhood leukemia: a therapeutic advances in childhood leukemia & lymphoma (TACL) study","volume":"22","author":"Cooper","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2019.11.005_bib97","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/2040620714532123","article-title":"The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond","volume":"5","author":"Wander","year":"2014","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.canlet.2019.11.005_bib98","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/leu.2017.216","article-title":"The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20\/RNF40\/WAC-H2B ubiquitination axis","volume":"32","author":"Garrido Castro","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2019.11.005_bib99","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V124.21.117.117","article-title":"A phase 1 study of the BET-bromodomain inhibitor OTX015 in patients with advanced acute leukemia","volume":"124","author":"Dombret","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.11.005_bib100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejca.2012.07.013","article-title":"Absence of global hypomethylation in promoter hypermethylated Mixed Lineage Leukaemia-rearranged infant acute lymphoblastic leukaemia","volume":"49","author":"Stumpel","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2019.11.005_bib101","article-title":"Final report of phase 1 study of the DOT1L inhibitor, pinometostat (EPZ-5676)","volume":"128","author":"Shukla","year":"2016"},{"key":"10.1016\/j.canlet.2019.11.005_bib102","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40262-017-0565-x","article-title":"Clinical pharmacokinetics and pharmacodynamics of panobinostat","volume":"57","author":"Van Veggel","year":"2018","journal-title":"Clin. Pharmacokinet."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519305609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519305609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:48:09Z","timestamp":1759592889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519305609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":102,"alternative-id":["S0304383519305609"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.11.005","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KMT2A rearranged acute lymphoblastic leukaemia: Unravelling the genomic complexity and heterogeneity of this high-risk disease","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}